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1. Introduction 
Blood glucose lowering sulfonamides do not only 
stimulate the release of insulin from the P-cell of the 
pancreas but have also extra-pancreatic effects. One 
of these effects is the inhibition of hepatic ketogenesis 
[l-3]. During recent studies of a new hypoglycemic 
sulfonylurea we observed not only an inhibition of 
ketogenesis but also of hepatic glucogeneogenesis. 
We present now data which show that glisoxepide, a 
new blood glucose lowering sulfonylurea, inhibits in 
rat liver specifically gluconeogenesis from L-lactate 
and L-alanine but not from pyruvate. Urea production 
from endogenous precursors as well as from L-alanine 
is likewise diminished. Gluconeogenesis from L-lactate 
is only slightly inhibited in pigeon liver. In isolated rat 
liver mitochondria glisoxepide inhibits specifically the 
L-aspartate/L-glutamate xchange. 
2. Materials and methods 
Male Wistar rats (Winkelmann, Kirchborchen/l 
Germany) fed a standard diet were used throughout 
the experiments. Pigeons between 15 and 20 weeks of 
age were purchased from Henning, Selters/Germany. 
Liver cells from 48 hr starved rats and 72 hr starved 
pigeons were prepared by a modification of the method 
of Berry and Friend [4]. No hyaluronidase was used. 
The isolated liver cells were incubated in Krebs-Ringer 
bicarbonate buffer, pH 7.4 equilibrated with carbogen 
(95% Oa ,5% COa) under the conditions mentioned in 
the legends to tables l-3. Mitochondria from rat liver 
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were isolated according to Chappel and Hansford [5]. 
For measuring the malonate/cr-oxoglutarate and the 
L-aspartate/L-glutamate xchange the change of the 
reduction of mitochondrial NAD(P) was registered by 
dual wavelength spectrophotometry with an Aminco- 
Chance DW 2 spectrophotometer as described by 
Azzi et al. [6]. In a similar way the transport of 
L-glutamate [6] and D-isocitrate [7] was studied. 
Inhibition of soluble and mitochondrial glutamate- 
oxaloacetate aminotransferase (EC 2.6.1 .l) from rat 
liver by glisoxepide was determined in the direction 
of oxaloacetate formation. The test mixture contained 
(final concentration): K-phosphate 85 mM; NADH 0.2 
mM; cw-oxoglutarate 15 mM; malate dehydrogenase 
(NH4+-free) 17 pg; appropiate amounts of Ss- or 
mitochondrial protein; L-aspartate (0.125-20 mM). 
Glucose, L-lactate, pyruvate, L-alanine, L-aspartate, 
and urea were determined enzymic-optically by stan- 
dard methods [8]. Enzymes and coenzymes came 
from Boehringer Mannheim Corp., Mannheim, Germany, 
carbony! cyanide, m-chlorophenyl hydrazone (CCCP) 
from Calbiochem, Luzern, Switzerland, antimycin A 
and rotenone from Sigma Chem. Co., St. Louis, Md., 
USA, and DL-isocitrate from Roth, Karlsruhe, Germany. 
All other reagents were ordered from E. Merck A.G., 
Darmstadt, Germany. Glisoxepide (1 -hexahydro-I -H- 
azepin-1 -yl)-3-((p-[2(5-methylisooxalol-3-carboxamido)- 
ethyl]-phenyl-sulfonyl))-urea) was a gift of Dr N. N. 
Kiesselbach, Farbenfabriken Bayer A. G., Pharmazeu- 
tisches Forschungszentrum, Wuppertal-E., Germany. 
Avenaciolide was kindly donated by Dr Turner Bio- 
chemistry Dept. Pharmaceutic. Div. ICI Ltd., 
Macclesfield Cheshire, England. 
North-Holland Publishing Company -Amsterdam 
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Table 1 
Effect of glisoxepide on gluconeogenesis from L-lactate, L-alanine, and L-lactate by 
isolated rat liver cells 
Experimental Concentration Glucose Formation L/P 
condition of production of L-lactate 
glisoxepide + pyruvate 
(M) (Mmo1.g dry weight’ - min-’ ) (ratio) 
Control @ 0.37 + 0.01 0.31 f 0.03 3.2 * 0.5 
no substrate 
L-Alanine @J 1.54 f 0.05 1.91 ? 0.21 3.3 f 0.2 
control 
L-Alanine 5*10‘4 0.85 + 0.01 2.28 r 0.22 5.4 + 0.4 
L-Alanine 1.10-4 0.88 f 0.03 2.07 f. 0.08 5.1 f 0.4 
L-Alanine 5.1o-5 1.20 * 0.01 1.86 + 0.01 4.5 f 0.1 
L-Alanine 2.5*10-’ 1.35 ? 0.04 1.88 + 0.09 3.8 f 0.3 
L-Lactate @ 2.53 f 0.02 - 10.6 f 0.9 
control 
L-Lactate 5*10-4 1.23 c 0.02 - 20.8 * 1.1 
L-Lactate 1*10-’ 1.77 c 0.10 - 15.6 + 0.3 
Pyruvate @ 2.79 f 0.02 - 1.0 * 0.2 
control 
Pyruvate 5.10-4 2.56 ? 0.01 - 1.0 + 0.2 
-~ 
The initial precursor concentration was always 10 mM. Cells were isolated as described in 
Materials and methods, Cells corresponding to 10 to 15 mg dry weight were incubated in 
a total vol of 2 ml and shaken in a waterbath at 37°C and 120 strokes/min for 60 min. 
The incubation was stopped by addition of 1 ml of 1 N HClO, (mean values c SEM) 
(n = 4). 
Table 2 
Comparative effects of glisoxepide (1 mM) and avenaciolide 
(0.5 mM) on gluconeogenesis and ureogenesis from 
endogenous precursors and from L-alanine (10 mM) in 
experiments with isolated rat liver cells from 48 hr starved rats 
Experimental 
condition 
Net formation Net formation 
- of glucose of urea 
(pmo1.g dry weight-’ . min“) 
No external precursor 
L-Alanine 
L-Alanine + 
glisoxepide 
L-Alanine + 
avenaciolide 
0.70 + 0.03 0.51 f 0.02 
1.67 * 0.02 2.40 f 0.03 
0.85 + 0.01 1.67 f 0.03 
0.72 f 0.02 1.30 f 0.04 
The conditions for isolation and incubation of cells were the 
same as mentioned in Materials and methods and in the 
legend to table 1. (n = 5). (Mean values + SEM). 
3. Results 
3.1. Effects on gluconeogenesis 
In isolated rat liver cells glisoxepide inhibited 
significantly gluconeogenesis from L-lactate and 
L-alanine, but not from pyruvate (table 1). In the 
experiments with L-lactate the lactate/pyruvate ratio 
was significantly higher in the presence of the inhibitor. 
Production of pyruvate + L-lactate from L-alanine 
was not diminished indicating that transamination was 
not significantly affected. Urea production in the 
presence of 10 mM L-lactate or pyruvate was inhi- 
bited by 26% and 36% resp. in the presence of 
1.10e4 M glisoxepide. Urea production from L- 
alanine was likewise inhibited (table 2) although less 
than by avenaciolide at a concentration which was 
about equieffective with respect to inhibition of 
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Table 3 
Effects of glisoxepide on gluconeogenesis from L-lactate (initial concentration 10 mM) 
by isolated pigeon Liver cells 
Experimental 
condition 
Concentration 
of 
glisoxepide 
(M) 
Glucose LIE 
formation 
(kmo1.g dry weight-’ * mm-’ ) (ratio) 
Control 
no substrate 
L-lactate 
L-lactate 
L-lactate 
L-lactate 
@ 0.48 k 0.02 _ 
@ 9.60 * 0.06 25 f. 0.8 
1*1o-3 7.59 * 0.05 36 ?I 3.2 
5.10-4 8.33 i 0.27 36 * 1.2 
l-lo-’ 9.43 * 0.04 33 f 0.1 
Isolation and incubation was performed as described in the legend to table 1. Each incuba- 
tion vessel contained cells corresponding to 3-5 mg dry weight (Mean values + SEM) 
(n = 4). 
gluconeogenesis. In isolated pigeon liver cells glisox- 
epide had only a weak inhibitory effect on gluconeo- 
genesis from L-lactate (table 3) although the lactate/ 
pyruvate ratio became also significantly reduced. 
3.2. Anion transport in isolated mitochondria 
The oxidation of NAD(P)H following the addition 
of L-aspartate was significantly decreased by glisoxepide 
(iig.la and lb). In addition the final redox state at which 
the NAD(P)/NAD(P)H system arrived after the addition 
of L-aspartate was shifted towards a less oxidized state. 
When the concentration of L-aspartate was 0.1 mM, 
the inhibition could still be seen at a glisoxepide con- 
centration as low as S-IO-’ M (figure 2a and 2b). The 
inhibition (Ki = 1 .5.10W4 M) was of the competitive 
type (insert in fig.2). The malonate/o-oxoglutarate 
exchange was not affected by varying the outer pH 
between 7.21 and 7.76 (fig.lc) whereas the aspartate/ 
glutamate exchange was inhibited at lower pH values 
(fig.1~). The inhibition of the aspartate/glutamate 
exchange by glisoxepide decreased with increasing pH 
(fig.ld). The uptake and/or adsorption of [3H]glisox- 
epide (not shown here) was not affected by pH changes 
between 7.20 and 7.80. 
The rate of reduction of NAD(P) following the 
addition of malonate was not affected by 1-1O-4 
glisoxepide and only slightly diminished by 5-10W4 M 
glisoxepide (insert in fig.3). The oxidation of L-gluta- 
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Fig.3. A) Lack of inhibition of L-glutamate transport by S-10-’ glisoxepide. Rat liver mitochondria (2.3 mg) were added to 
potassium hydroxyethylpiperazine-ethanesulphonate (80 mM; pH 6.8). Oxidation of intramitochondrial NAD(P)H was achieved 
by addition of CCCP (1 PM). Antimycin (0.5 pg/ml) and rotenone 2 ng/ml were added. Reduction of NAD(P) was initiated by 
addition (CLU) of L-glutamate (2.5 mM). Glisoexepide had been added 2 minutes prior to the addition of L-glutamate. The 
total volume was 3 ml. Reaction temperature 30”C.lnserf in figure 3A: Effect of ghsoxepide on the malonate induced transport 
of ol-oxoglutarate. Conditions were as given in the legend to fig.1 A except that glisoxepide was added before the addition of 
a-oxoglutarate. Concentration of mitochondria was 0.8 mg/ml. B) Lack of inhibition of transport of isocitrate by glisoxepide. 
Rat liver mitochondria (2.3 mg) were suspended in the same medium as given in the legend to figure 1A. Oxidation of NAD(P)H 
was achieved by CCCP, and rotenone and antimycin were added as described in the same legend. A slow reduction of NAD(P) 
was initiated by the addition of D, L-isocitrate (2.5 mM). A rapid reduction followed immediately after addition (MAL) of 
L-malate (0.42 mM). Glisoxepide (5*10-’ M) was added 2 minutes prior to the addition of D, L-isocitrate. The total volume 
was 3.0 ml, the reaction temperature 26°C. Figures 3A and 3B were redrawn from original curves. 
Fig.1. A) Control experiment. About 2.5 mg of rat liver mitochondria were incubated in the following medium; Tri.-Cl20 mM, KC1 
80 mM, K-phosphate 1 mM, pH 7.4. Oxidation of NAD(P) was initiated by carbonyl cyanide, m-chlorophenyl hydrazone (CCCP) 
(1 MM). After completion of oxidation antimycin (0.5 &ml) and rotenone (2 Ng/ml) were added, followed by the addition of o- 
oxoglutarate (1 mM). Reduction of NAD(P) was initiated by addition of malonate (1 mM). After completion of reduction glutamate 
(1 mM) was added, Re-oxidation was initiated by addition of L-aspartate (1 mM). The total vol was 3 ml. Reaction temperature 
30°C. B) Same experiment as in (A) with the exception that glisoxepide (5.10-’ M) was added before the addition of L-aspartate. 
(C) Same type of experiment as in (A)..The concentration of Laspartate was 0.1 mM. The pH values were varied between 7.21 and 
7.76. Note that NAD(P) reduction is not affected by the pH changes. D) These experiments were carried out as those shown in (C) 
but l-10-’ glisoxepide was added before the addition of L-aspartate. 
Fig.2. A) Inhibitory effect of 5*10‘5 M glisoxepide on the transport of L-aspartate at a low concentration of aspartate. Rat livdr 
mitochondria (2.1 mg) were incubated under the same condition as described in the legend to fig.l(A) and (B) with the exception 
that the concentration of aspartate was only 0.1 M. Reaction temperature 30°C. B) Same experiment as in (A), but the concentra- 
tion of glisoxepide was reduced to 5.10m7 M. The insert represents the graphical evaluation of Ki by a Dixon plot. 
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TIME (SECONDS 1 
Fig.4. Effect of glisoxepide on the L-glutamate induced 
efflux of L-aspartate from isolated rat liver mitochondria 
(4.5 mg/ml). Mitochondria were isolated in mannitol(0.225 M) 
sucrose (75 mM), EDTA (0.1 mM) at pH 7.4. The mitochondria 
were loaded with L-glutamate and the intramitochondrial 
formation of L-aspartate was induced by addition of oxa- 
loacetate (2 mM) as described by LaNoue et al. [9]. At zero 
time L-glutamate (5 mM) was added to the incubation medium. 
At the time points indicated in the figure aliquots of the 
incubation mixture were layered on top of a silicon oil phase 
and mitochondria were separated by rapid centrifugation in 
an Eppendorf-centrifuge with swing-out rotor. l ------• 
Controls + L-glutamate; o- o glisoxepide, 0.25 mM, + 
L-glutamate; a- .Q glisoxepide, 5 mM, + L-glutamate; 
w.-.-.-¤ Controls without L-glutamate (0.25 mM glisoxepide 
without L-glutamate gave identical values); q - 0 glisox- 
epide, 5 mM, without L-glutamate. Inserf: Net formation 
of L-aspartate (extra- plus intramitochondrial) at 1, 2, and 3 
minutes after addition of 2 mM oxaloacetate to L-glutamate 
loaded mitochondria in the absence (0 -0) and presence 
(o- 0) of 5 mM glisoxepide. 
mate (fig3a) or D-isocitrate (fig.3b) was not affected 
by glisoxepide up to concentrations of 5~.10-~ M. No 
inhibition of soluble or mitochondrial glutamate- 
oxaloacetate aminotransferase could be observed at 
Laspartate concentrations from 0.125 to 20 mM when 
the concentration of glisoxepide was varied between 
5.10W6 and 5.10m3 M. Only concentrations exceeding 
5 mM caused some inhibition of soluble and mitochon- 
drial glutamate-oxaloacetate amino transferase. 
When isolated rat liver mitochondria were charged 
with L-aspartate as described by La-Noue et al. [9] 
and the outward transport of L-aspartate after addi- 
tion of L-glutamate was measured 0.25 mM glisoxepide 
had no significant effect (fig.4). However, the concen- 
tration of L-aspartate in the matrix water space was 
between 10 and 20 mM under these conditions. This 
explains the inefficiency of the inhibitor since, accord- 
ing to the experiments described above, the inhibition 
by glisoxepide is competitive with aspartate. When the 
outward transport of L-aspartate was measured in the 
presence of 5 mM glisoxepide (fig.4) the inhibition of 
formation of L-aspartate interfered with the inhibition 
of transport (insert in fig.4). Further experiments are 
underway in order to discriminate between these two 
phenomena. 
4. Discussion 
Glisoxepide is a rather specific inhibitor of the L- 
aspartate/L-glutamate antiport system. According to 
LaNoue et al. [9] the L-aspartate/L-glutamate xchange 
is electrogenic and proceeds under physiological condi- 
tions unidirectionally from the matrix space to the 
outside. However, under our conditions the trans- 
membrane pH-gradient had been abolished by the use 
of an uncoupler in combination with inhibitors of 
respiration. Under this condition, external L-aspartate 
can exchange with internal L-glutamate. In accordance 
with this is the finding that lowering of the external pH 
inhibited the L-aspartate/L-glutamate xchange but 
increased the inhibitory action of glisoxepide. The drug 
did not only diminish the rate of oxidation of intra- 
mitochondrial NAD(P)H but shifted also the final 
redox state of the NAD(P)‘/NAD(P)H system towards 
a higher degree of reduction. Since the redox state 
results from the oxidation of a-oxoglutarate and the 
reduction of oxaloacetate, an inhibition of intra- 
mitochondrial transamination due to a lack of incoming 
Laspartate will diminish formation of NAD(P)H in the 
malate dehydrogenase reaction and leave more (Y-OXO- 
glutarate and L-glutamate for oxidation. The rather 
selective inhibition of gluconeogenesis from L-lactate 
and L-alanine together with an inhibition of ureogenesis 
would be in line with the concept that gluconeogenesis 
from these two precursors but not that from pyruvate 
involves transamination and transport of L-aspartate out 
of the mitochondria [IO- 121. The low sensitivity of 
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gluconeogenesis from L-lactate towards the drug in 
isolated pigeon liver cells fits also this concept, since 
in this species no transamination cycle is involved in 
gluconeogenesis from L-lactate [ 131. Glisoxepide 
inhibited ureogenesis from endogenous precursors and 
from L-alanine. The higher degree of inhibition of 
ureogenesis by avenaciolide reflects most probably 
additional unspecific effects as is indicated by an inhi- 
bition (-22%) of gluconeogenesis from pyruvate under 
the same conditions. 
Sulfonylureas could contribute to an inhibition of 
gluconeogenesis also by affecting oxidative phosphory- 
lation [ 14-161. However, if this were the main reason 
for the results obtained in this study one would expect 
a similar inhibition of gluconeogenesis from pyruvate. 
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